EUVIMEDDescubrir EUVIMED
Open access · CC BY-NC 4.0

Development and Evaluation of a Plumbagin-Brinzolamide Binary Cocrystals for Improved Aqueous Solubility

Kalyani Sakure, Alok Singh Thakur, Madhulika Pradhan, Vinay Sagar Verma, Hemant Badwaik

Journal of Pharma Insights and Research · 2026-04-05 · 4 (2) · 159-166

DOI: 10.69613/jtceda41 ↗

At a glance

Journal article in Journal of Pharma Insights and Research, published online on 2026-04-05. Written by Kalyani Sakure and 4 co-authors. The full text is freely available (open access, CC BY-NC 4.0).

ResumenDatos bibliográficosCiteRelated studies

Abstract (original language)

Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) is a secondary metabolite which exhibit antioxidant, anti-inflammatory, and anticancer properties. Although therapeutically active, its clinical application is limited due to its poor aqueous solubility, which leads to suboptimal oral bioavailability and rapid systemic clearance. This research work aimed at the fabrication of a novel pharmaceutical cocrystal involving plumbagin and brinzolamide (PLB–BRZ) as an intervention to alter the physicochemical limitations of the parent phytoconstituent. The preparation of cocrystals involved three distinct approaches: neat grinding, liquid-assisted grinding, and solution crystallization across multiple stoichiometric ratios. Solid-state characterization of prepared cocrystals was carried out using Fourier Transform Infrared Spectroscopy (FTIR), Powder X-ray Diffraction (PXRD), Scanning Electron Microscopy (SEM), and Thermogravimetric Analysis (TGA) and the tests confirmed the formation of a distinct crystalline phase characterized by unique supramolecular synthons. Saturation solubility experiments in diverse media, including distilled water, 0.1 N HCl, and pH 6.8 phosphate buffer, revealed that the cocrystal prepared via solution crystallization (1:1 ratio) achieved a solubility increase exceeding 120% compared to pure plumbagin. These results show that the addition of plumbagin into a multicomponent crystalline lattice with brinzolamide effectively alters the hydration energy and lattice strength, providing a viable pathway for the development of high-performance botanical formulations. The results support the utility of supramolecular chemistry in overcoming the inherent delivery challenges associated with hydrophobic naphthoquinones

Cite

APA

Sakure, K., Thakur, A. S., Pradhan, M., Verma, V. S., & Badwaik, H. (2026). Development and Evaluation of a Plumbagin-Brinzolamide Binary Cocrystals for Improved Aqueous Solubility. Journal of Pharma Insights and Research, 4(2), 159-166. https://doi.org/10.69613/jtceda41

Vancouver

Sakure K, Thakur AS, Pradhan M, Verma VS, Badwaik H. Development and Evaluation of a Plumbagin-Brinzolamide Binary Cocrystals for Improved Aqueous Solubility. Journal of Pharma Insights and Research. 2026;4(2):159-166. doi:10.69613/jtceda41

BibTeX
@article{Sakure2026,
  author = {Sakure, Kalyani and Thakur, Alok Singh and Pradhan, Madhulika and Verma, Vinay Sagar and Badwaik, Hemant},
  title = {Development and Evaluation of a Plumbagin-Brinzolamide Binary Cocrystals for Improved Aqueous Solubility},
  journal = {Journal of Pharma Insights and Research},
  year = {2026},
  volume = {4},
  number = {2},
  pages = {159--166},
  doi = {10.69613/jtceda41}
}
Start for free →